Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Clinical trial NCT05801705 · UNKNOWN

Trial details

NCT number: NCT05801705
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Study type: OBSERVATIONAL

Hormone-receptor-positive Breast Cancer Premenopausal Breast Cancer Breast Cancer Patients at Intermediate to High Risk Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or Torimefen

Start date: 2023-06-01
Primary completion: 2023-06-30
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.